文献速递流行病学与生物统计临床试验与 GCP

根据临床概率及临床重要亚组,使用计算机断层扫描血管造影诊断稳定胸痛患者阻塞性冠状动脉疾病:个体患者数据的荟萃分析

Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data.
PubMed 文献 · BMJ · 2019-06-12

该研究为前瞻性设计的个体患者数据荟萃分析,纳入65项前瞻性诊断准确性研究的5332例患者,评估冠状动脉CTA诊断阻塞性CAD的预测价值。在治疗阈值模型下,临床验前概率7-67%时诊断准确性最高,阳性预测值从7%时的50.9%升至67%时的82.7%,阴性预测值从97.8%降至85.0%。CTA总体敏感度95.2%、特异度79.2%,>64排探测器敏感度和特异度均高于≤64排,女性及75岁以上患者诊断性能略低。

要点

  • 临床验前概率7-67%时冠状动脉CTA诊断阻塞性CAD准确性最高。
  • CTA总体敏感度95.2%、特异度79.2%,>64排探测器性能更优。
  • 诊断性能在男性略高、75岁以上略低,不受心绞痛类型显著影响。

核心结论

  • 在无治疗/治疗阈值模型中,稳定胸痛患者临床验前概率在7%至67%之间时,冠状动脉CTA诊断阻塞性CAD最为准确。
  • CTA诊断性能不受心绞痛类型影响,男性略高,老年患者略低。

研究设计与样本

  • 前瞻性设计的个体患者数据荟萃分析,纳入65项前瞻性诊断准确性研究,共5332例患者。
  • 检索Medline、Embase和Web of Science,并通过直接联系研究者获取未发表研究。
  • 纳入标准为以冠状动脉造影为参考标准、直径狭窄≥50%定义阻塞性CAD的前瞻性诊断准确性研究,所有患者均有冠状动脉造影临床指征且均接受两种检查。
  • 主要结局为CTA阳性预测值和阴性预测值随临床验前概率的变化,采用广义线性混合模型分析,计算时包括和不包括非诊断性CTA结果。
  • 使用无治疗/治疗阈值模型确定CTA的适当验前概率范围,阈值基于阴性CTA后验概率<15%、阳性CTA后验概率>50%。

主要发现

  • 验前概率7%时,CTA阳性预测值为50.9%(95%CI 43.3%至57.7%),阴性预测值为97.8%(95%CI 96.4%至98.7%)。
  • 验前概率67%时,CTA阳性预测值为82.7%(95%CI 78.3%至86.2%),阴性预测值为85.0%(95%CI 80.2%至88.9%)。
  • CTA总体敏感度为95.2%(95%CI 92.6%至96.9%),特异度为79.2%(95%CI 74.9%至82.9%)。
  • 使用>64排探测器的CTA敏感度高于≤64排(93.4% vs 86.5%,P=0.002),特异度也更高(84.4% vs 72.6%,P<0.001)。
  • CTA的ROC曲线下面积为0.897(95%CI 0.889至0.906),女性略低于男性(0.874(95%CI 0.858至0.890)vs 0.907(95%CI 0.897至0.916),P<0.001);75岁以上患者略低于其他年龄组(0.864(95%CI 0.834至0.894),P=0.018);心绞痛类型间无显著差异(典型心绞痛0.895(95%CI 0.873至0.917),非典型心绞痛0.898(95%CI 0.884至0.913),非心绞痛性胸痛0.884(95%CI 0.870至0.899),其他胸部不适0.915(95%CI 0.897至0.934))。

临床怎么用

  • 作者结论认为,在无治疗/治疗阈值模型中,稳定胸痛患者临床验前概率在7%至67%之间时,使用冠状动脉CTA诊断阻塞性CAD最为准确。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether coronary computed tomography angiography (CTA) should be performed in patients with any clinical probability of coronary artery disease (CAD), and whether the diagnostic performance differs between subgroups of patients. DESIGN: Prospectively designed meta-analysis of individual patient data from prospective diagnostic accuracy studies. DATA SOURCES: Medline, Embase, and Web of Science for published studies. Unpublished studies were identified via direct contact with participating investigators. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Prospective diagnostic accuracy studies that compared coronary CTA with coronary angiography as the reference standard, using at least a 50% diameter reduction as a cutoff value for obstructive CAD. All patients needed to have a clinical indication for coronary angiography due to suspected CAD, and both tests had to be performed in all patients. Results had to be provided using 2×2 or 3×2 cross tabulations for the comparison of CTA with coronary angiography. Primary outcomes were the positive and negative predictive values of CTA as a function of clinical pretest probability of obstructive CAD, analysed by a generalised linear mixed model; calculations were performed including and excluding non-diagnostic CTA results. The no-treat/treat threshold model was used to determine the range of appropriate pretest probabilities for CTA. The threshold model was based on obtained post-test probabilities of less than 15% in case of negative CTA and above 50% in case of positive CTA. Sex, angina pectoris type, age, and number of computed tomography detector rows were used as clinical variables to analyse the diagnostic performance in relevant subgroups. RESULTS: Individual patient data from 5332 patients from 65 prospective diagnostic accuracy studies were retrieved. For a pretest probability range of 7-67%, the treat threshold of more than 50% and the no-treat threshold of less than 15% post-test probability were obtained using CTA. At a pretest probability of 7%, the positive predictive value of CTA was 50.9% (95% confidence interval 43.3% to 57.7%) and the negative predictive value of CTA was 97.8% (96.4% to 98.7%); corresponding values at a pretest probability of 67% were 82.7% (78.3% to 86.2%) and 85.0% (80.2% to 88.9%), respectively. The overall sensitivity of CTA was 95.2% (92.6% to 96.9%) and the specificity was 79.2% (74.9% to 82.9%). CTA using more than 64 detector rows was associated with a higher empirical sensitivity than CTA using up to 64 rows (93.4% v 86.5%, P=0.002) and specificity (84.4% v 72.6%, P<0.001). The area under the receiver-operating-characteristic curve for CTA was 0.897 (0.889 to 0.906), and the diagnostic performance of CTA was slightly lower in women than in with men (area under the curve 0.874 (0.858 to 0.890) v 0.907 (0.897 to 0.916), P<0.001). The diagnostic performance of CTA was slightly lower in patients older than 75 (0.864 (0.834 to 0.894), P=0.018 v all other age groups) and was not significantly influenced by angina pectoris type (typical angina 0.895 (0.873 to 0.917), atypical angina 0.898 (0.884 to 0.913), non-anginal chest pain 0.884 (0.870 to 0.899), other chest discomfort 0.915 (0.897 to 0.934)). CONCLUSIONS: In a no-treat/treat threshold model, the diagnosis of obstructive CAD using coronary CTA in patients with stable chest pain was most accurate when the clinical pretest probability was between 7% and 67%. Performance of CTA was not influenced by the angina pectoris type and was slightly higher in men and lower in older patients. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42012002780.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Haase R, Schlattmann P, Gueret P, et al. Diagnosis of obstructive coronary artery disease using computed tomography angiography in patients with stable chest pain depending on clinical probability and in clinically important subgroups: meta-analysis of individual patient data. BMJ. 2019. PMID: 31189617. doi:10.1136/bmj.l1945

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。